ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2025; 15(5): 121-128


Active fraction of Ciplukan (Physalis angulata L.) increases phosphorylation on IRS-1 Tyr-612 and Akt Ser-473 in 24-hour incubation time

Felicia Beta Papilaya, Mae Sri Hartati Wahyuningsih, Rul Afiyah Syarif.



Abstract
Download PDF Post

Diabetes mellitus (DM) is a chronic metabolic disorder marked by elevated blood glucose levels due to insufficient insulin production or action. This condition has become a major health concern globally, including in Indonesia. The increasing prevalence of DM in Indonesia poses significant health challenges, prompting exploration of traditional medicinal plants as alternative treatments. Ciplukan (Physalis angulata Linn) is known for its antidiabetic effect in Indonesians. Previous studies showed that the active fraction (AF) increased glucose absorption in C2C12 cells. This study aims to investigate the effect of P. angulata’s AF on insulin receptor substrate-1 (IRS-1) Tyr-612 and Akt Ser-473 phosphorylation in insulin-resistant C2C12 cells. Treatment of well-differentiated C2C12 cells with palmitate was conducted to induce insulin resistance. The insulin-resistant C2C12 cells were divided into four groups: the negative control and the treated groups each with 4-, 12- and 24-hour incubation time. Expression of p-IRS-1 Tyr-612 and p-Akt Ser-473 in insulin-resistant C2C12 cells was measured by a western blot analysis. The AF of P. angulata appeared to have an antidiabetic effect by increasing phosphorylation of IRS-1 Tyr-612 and Akt Ser-473 in insulin-resistant C2C12 cells after 24 hours of incubation (p < 0.05).

Key words: P. angulata’s active fraction; C2C12 cells; insulin resistance; IRS-1 Tyr-612; Akt Ser-473







Bibliomed Article Statistics

22
27
35
22
16
10
8
11
20
26
1
R
E
A
D
S

25

12

29

12

12

11

12

15

20

22


D
O
W
N
L
O
A
D
S
0405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.